Klöckner Pentaplast Invests in Brazil Facility

The investment is to expand capacity at its Cotia location to enable new products to be manufactured in the region.

Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division (kp Pharma) announces a 5 million Euro investment in their Cotia, Brazil facility.

Tracey Peacock, kp’s President, Pharmaceutical & Medical Device Films, says, “We are seeing substantial growth in our high-barrier product segments in South America in response to the increased temperature, moisture and oxygen-sensitivity of new drugs. We are excited to support this key mega trend by adding significant capacity and technical capability to support new products into our Cotia facility.”

This latest investment comes about two years after the addition of the fourth slitting line in Cotia, which increased the current site’s slitting capacity by ~4.000 tons/yr.

“We expect the new capability to be operational from July 2019 with the “simple aim of improving service to our customers wherever they are located in the South American region,” adds Peacock.

Companies in this article
More in Home